Join to View Full Profile
13737 N 92nd StScottsdale, AZ 85260
Phone+1 480-301-8000
Dr. Armas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Family Medicine, 2006 - 2009- Mayo Clinic College of MedicineClass of 2006
Certifications & Licensure
AZ State Medical License 2007 - 2027
American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) Start of enrollment: 2021 Jul 16
Roles: Contact
- A Study of TAK-227 in Healthy Adults Start of enrollment: 2023 May 25
Roles: Principal Investigator
Publications & Presentations
PubMed
- 1 citationsFood Effect and Pharmacokinetic Bridging of Avacopan in Caucasian and Japanese Healthy Participants.Shichang Miao, Pirow Bekker, Danielle Armas, Mary Lor, Ryuzo Hanada
Clinical Pharmacology in Drug Development. 2024-09-01 - 1 citationsA phase I thorough QT/QTc study evaluating therapeutic and supratherapeutic doses of avacopan in healthy participants.Shichang Miao, Peter Staehr, Ezra Tai, Borje Darpo, Hongqi Xue
Clinical and Translational Science. 2024-07-01 - 3 citationsPharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug-Drug Interaction of Avacopan in 2 Open-Label Studies in Healthy Participants.Shichang Miao, Pirow Bekker, Danielle Armas, Mary Lor, Yanyan Han
Clinical Pharmacology in Drug Development. 2024-05-01
Press Mentions
Xeris Pharmaceuticals Completes Enrollment of Its Phase 1 Study of Levothyroxine (XP-8121)September 1st, 2021
Effects of Rifampin on the Pharmacokinetics of a Single Dose of Istradefylline in Healthy SubjectsSeptember 7th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
